Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P J Goebell

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Der Urologe. Ausg. A|July 7, 2018
[An essay on health services research-contributions from urology]P J Goebell
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|May 20, 2009
Outcomes and response to therapy in bladder cancer. Are biomarkers of any help?P J Goebell
Der Urologe. Ausg. A|July 9, 2020
[Sectoral interface-an opportunity for health services research?]P J Goebell
Der Urologe. Ausg. A|August 28, 2019
[Guideline adherence]S Krege, P J Goebell
Aktuelle Urologie|October 22, 2015
[Molecular Concepts of Immunomodulation for the Treatment of Metastatic Renal Cell Carcinomas: Where are We Now?]P J Goebell, J Bedke
Onkologie|September 16, 2003
Perioperative chemotherapy in advanced bladder cancer: part I. Neoadjuvant treatmentP J Goebell, T Otto, H Rübben
Der Urologe. Ausg. A|June 9, 2019
[Molecular tumor board-renal cell carcinoma]V Grünwald, C Doehn, P J Goebell
Der Urologe. Ausg. A|April 18, 2018
[Follow-up of bladder cancer : The right examinations at the right time]P Olbert, P J Goebell, A Hegele
Onkologie|November 8, 2003
Perioperative Chemotherapy in Advanced Bladder Cancer - Part II: Adjuvant TreatmentT Otto, P J Goebell, H Rübben
Der Urologe. Ausg. A|March 5, 2019
[Presurgical assessments]A Kahlmeyer, P J Goebell, B Wullich
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Der Urologe. Ausg. A|July 7, 2018
[An essay on health services research-contributions from urology]P J Goebell
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|May 20, 2009
Outcomes and response to therapy in bladder cancer. Are biomarkers of any help?P J Goebell
Der Urologe. Ausg. A|July 9, 2020
[Sectoral interface-an opportunity for health services research?]P J Goebell
Der Urologe. Ausg. A|August 28, 2019
[Guideline adherence]S Krege, P J Goebell
Aktuelle Urologie|October 22, 2015
[Molecular Concepts of Immunomodulation for the Treatment of Metastatic Renal Cell Carcinomas: Where are We Now?]P J Goebell, J Bedke
Onkologie|September 16, 2003
Perioperative chemotherapy in advanced bladder cancer: part I. Neoadjuvant treatmentP J Goebell, T Otto, H Rübben
Der Urologe. Ausg. A|June 9, 2019
[Molecular tumor board-renal cell carcinoma]V Grünwald, C Doehn, P J Goebell
Der Urologe. Ausg. A|April 18, 2018
[Follow-up of bladder cancer : The right examinations at the right time]P Olbert, P J Goebell, A Hegele
Onkologie|November 8, 2003
Perioperative Chemotherapy in Advanced Bladder Cancer - Part II: Adjuvant TreatmentT Otto, P J Goebell, H Rübben
Der Urologe. Ausg. A|March 5, 2019
[Presurgical assessments]A Kahlmeyer, P J Goebell, B Wullich
Pageof 4